Stay updated on Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.

Latest updates to the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check25 days agoChange Detected- Revision label updated from v3.4.2 to v3.4.3 in the page footer. - No impact on study data or user workflow.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision label, v3.4.2, was added to the history. The deleted notices include a government funding status notice and the older v3.4.1 entry, reflecting administrative updates to the page's version history.SummaryDifference0.7%

- Check61 days agoChange DetectedAdded a general site status notice about government funding lapse and the NIH Clinical Center's status. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.7%

- Check68 days agoChange DetectedThe history view now includes a glossary toggle and color-coded diffs (green for additions, red for deletions) with explicit revision notes (e.g., Revision: v3.4.0) to improve clarity of changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check82 days agoChange DetectedMinor site revision update from v3.3.3 to v3.3.4; it does not alter study data or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.